Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00161486 · ClinicalTrials.gov registry record · Phase 1
The Effects of Testosterone on Prostate Tissue (ACYP-1)
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00161486 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 13 participants.
The verdict
NCT00161486, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.
Interventions
- DRUG Acyline
- DRUG Testosterone gel
- DRUG Placebo acyline
- DRUG Placebo Testosterone gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2004-07 |
| Est. Completion | 2004-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00161486
The ClinicalTrials.gov registry entry for NCT00161486 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Acyline is the first listed.
NCT00161486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00161486 about?
NCT00161486 is a clinical study titled "The Effects of Testosterone on Prostate Tissue (ACYP-1)". The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.
What is the current status of trial NCT00161486?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2004-07. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00161486?
The interventions under investigation include: Acyline (DRUG), Testosterone gel (DRUG), Placebo acyline (DRUG), Placebo Testosterone gel (DRUG).
Who is sponsoring clinical trial NCT00161486?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.